Are you Dr. Womack?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 87 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
605 Glenwood Dr
Ste 200
Chattanooga, TN 37404Phone+1 423-698-1844Fax+1 423-624-2226
Summary
- Dr. Mark Womack IV, MD is an oncologist in Chattanooga, Tennessee. He is currently licensed to practice medicine in Tennessee, Georgia, and Alabama. He is affiliated with CHI Memorial.
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011- University of Alabama Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Tennessee Health Science Center College of MedicineClass of 2005
Certifications & Licensure
GA State Medical License 2011 - 2026
TN State Medical License 2011 - 2026
AL State Medical License 2007 - 2011- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012
Publications & Presentations
PubMed
- 39 citationsA Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H. Ko, Patrick B. Murphy, James D. Peyton, Dianna Shipley, Ahmed Al-Hazzouri
The Oncologist. 2017-12-01 - Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic...Faithlore P Gardner, Zev A Wainberg, Christos Fountzilas, Nathan Bahary, Mark S Womack
Cancers. 2024-03-28
Press Mentions
Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium™January 4th, 2021
HIV Drug Shows Promising Results in Treating COVID-19 PatientsApril 6th, 2020
